Increased Pro-MMP-9 protein expression secondary to STAT5a overexpression and 17-β-Estradiol treatment suggest a hormonal regulation of DCIS progression with this transcription factor. The gene discussed is STAT5A; the disease is ductal breast carcinoma in situ.